Leadartis 

Molecular engineering for health

OWNER

Juan Jose Perez Villar (See Profile)

Sector

Biotech

Stage

Development, market readiness, clinical trial

Country

Spain


Multi-valent/specific agonist tumor directed therapeutic trimerbodies with clear advantages over conventional antibodies

Preclinical results show in vivo tumor regression and generation of long-term protective immunological memory

Promising preclinical results could translate into an Early Exit or co-development with mid / large Pharma

This information is confidential, do not share or copy.

Under evaluation at least till: 24th June

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2020 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar